![](/sites/default/files/styles/az_large/public/default_images/startup_placeholder_0.png?itok=sgkL21UG)
Life Sciences
Regenerix LLC
Year
2023
Regenerix is developing therapies for neurodegenerative disorders utilizing next-generation RIPK1/RIPK3 inhibitors.
Company Status
Active
UArizona Inventors
May Khanna
Vijay Gokhale
Jonathan Lares Sanchez
College
College of Medicine - Tucson, BIO5 Institute, College of Pharmacy